TRPA1 mediates inflammation and scratching associated with allergic contact dermatitis; these symptoms can be mitigated by the genetic ablation of the TRPA1 gene or the administration of the TRPA1 channel antagonists HC030031 and A-967079 (Liu et al., 2013). The gene discussed is TRPA1; the disease is allergic contact dermatitis.